Regulatory Compliance of EDC Systems: Ensuring the Integrity of Your Clinical Data

Written by
Florentin Ory
Published on
October 1, 2025

Electronic Data Capture (EDC) systems are technology platforms that not only enable efficient collection and management of clinical trial data but also ensure compliance with the most stringent international standards. By choosing a compliant EDC system, research organizations guarantee the legal validity of their data, full traceability, and acceptance by global regulatory authorities.

This compliance is more than just an obligation; it is a mark of quality and credibility that protects the scientific integrity of your research.

Applicable Regulations
Regulation Geographic Scope Application Domain
21 CFR Part 11 United States Electronic records and electronic signatures
ICH GCP R3 International Good Clinical Practice (Revision 3)
ISO 27001 International Information security and data hosting
GDPR European Union Personal data protection
EMA Annex 11 European Union Computerized systems
EMA Guideline on Computerised Systems and Electronic Data in Clinical Trials European Union Computerized systems and electronic trial data
HIPAA United States Protection of personal health information (PHI)

The regulatory landscape of clinical trials imposes strict standards on data management systems. Complexity varies by region, with Europe considered one of the most regulated areas in the world. This European rigor naturally drives vendors based in the region to develop solutions of inherently higher quality.

EDC Systems and HIPAA Requirements

EDC systems must comply with HIPAA (Health Insurance Portability and Accountability Act) when processing personal health information (PHI) in the United States. HIPAA sets strict standards for the confidentiality, security, and traceability of medical data.

A HIPAA-compliant EDC must provide:

  • Data encryption

  • Secure access controls

  • A complete audit trail

  • Protected backups

HIPAA compliance is critical to safeguarding patients and avoiding legal penalties.

Importance of 21 CFR Part 11 Compliance

21 CFR Part 11 sets the criteria for managing electronic records and electronic signatures in regulated environments. Its objective is to ensure that electronic systems used for capturing, storing, and transmitting data deliver the same level of security, integrity, and reliability as traditional paper records.

It imposes strict requirements in terms of:

  • Data protection: Preventing unauthorized changes and corruption of electronic records.

  • Traceability: A complete audit trail recording every user action, including modifications, deletions, and additions.

  • Timestamping: Accurate, immutable recording of dates and times of all operations.

  • Secure electronic signatures: Mechanisms ensuring signatures are unique, tamper-proof, and attributable to the individual concerned.

  • Access control: Role-based permissions to limit access to sensitive data.

A system compliant with 21 CFR Part 11 issued by the U.S. FDA ensures that electronic records have the same legal value as paper documents, which is critical during inspections or regulatory submissions.

Key Features to Look for in a Compliant EDC System

A compliant EDC system must guarantee security, integrity, and traceability of clinical data. Essential technical features include:

  • Data security and hosting (ISO 27001): Certified hosting, data encryption in transit and at rest (TLS 1.2+, AES-256), strong authentication, and role-based access.

  • Traceability: Immutable audit trails recording modifications, user identity, and timestamps for full transparency during inspections.

  • Compliance by design and by default: Validated architecture and built-in safeguards integrated from the start.

  • Backup and recovery: Automated backups and rapid recovery to prevent data loss.

  • Data locking and signatures: Database locking for submission-ready datasets and secure electronic signatures to ensure data integrity and accountability.

  • Regulatory reports: Generation of traceable reports compliant with authority standards.

  • Rights and roles management: Precise access control (by role, site, or module) ensuring separation of responsibilities.

Datacapt: A Benchmark for Regulatory-Compliant EDC

At Datacapt, we embody excellence in regulatory compliance. Our French solution natively integrates all international standards, delivering a unified platform capable of managing diverse regulatory contexts.

Datacapt Advantages
Datacapt Advantage User Benefit
Native secure architecture Immediate security without the need for complex configurations.
Data protection European-born solution integrating strict privacy standards (GDPR and others) by default.
Compliance by design & by default Full regulatory compliance from installation, with no additional effort required.
Advanced audit trail Detailed and transparent monitoring through complete and immutable audit trails.
Optimized for clinical research Specialized tool with full features aligned with Good Clinical Practice (GCP).
Customizable workflows Total flexibility to adapt processes to the specific needs of each clinical project.

Thanks to its secure architecture and advanced traceability features, Datacapt enables research teams to focus on what matters most: the quality of their clinical studies. This global approach simplifies trial management while maintaining the highest level of compliance.

Challenges and Best Practices in Selecting a Compliant EDC System

How to choose the most suitable EDC system? The first step is to evaluate the regulatory coverage of the vendor. A high-quality system should simultaneously address all international contexts.

Priority selection criteria include:

  • Comprehensive regulatory coverage (ISO 27001, HDS for France/Europe, GCP, HIPAA, GDPR, 21 CFR Part 11)

  • Vendor expertise that extends beyond technology into regulatory guidance

  • Support in understanding regulatory obligations

The vendor’s expertise is a determining factor. A true partner not only provides technology but also helps navigate the complex regulatory landscape relevant to your specific context.

Let's Shape the Future of Clinical Trial Together!

Florentin Ory
CEO & Co-Founder

Florentin combines clinical research know-how with a true passion for product design. Attentive to detail and obsessed with user experience, he ensures that Datacapt remains a high-performance platform that’s also intuitive and accessible to every user.